Skip to main content

Advertisement

Log in

Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study

  • Breast
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the prediction performance of deep convolutional neural network (DCNN) based on ultrasound (US) images for the assessment of breast cancer molecular subtypes.

Methods

A dataset of 4828 US images from 1275 patients with primary breast cancer were used as the training samples. DCNN models were constructed primarily to predict the four St. Gallen molecular subtypes and secondarily to identify luminal disease from non-luminal disease based on the ground truth from immunohistochemical of whole tumor surgical specimen. US images from two other institutions were retained as independent test sets to validate the system. The models’ performance was analyzed using per-class accuracy, positive predictive value (PPV), and Matthews correlation coefficient (MCC).

Results

The model achieved good performance in identifying the four breast cancer molecular subtypes in the two test sets, with accuracy ranging from 80.07% (95% CI, 76.49–83.23%) to 97.02% (95% CI, 95.22–98.16%) and 87.94% (95% CI, 85.08–90.31%) to 98.83% (95% CI, 97.60–99.43) for the two test cohorts for each sub-category, respectively. In terms of 4-class weighted average MCC, the model achieved 0.59 for test cohort A and 0.79 for test cohort B. Specifically, the DCNN also yielded good diagnostic performance in discriminating luminal disease from non-luminal disease, with a PPV of 93.29% (95% CI, 90.63–95.23%) and 88.21% (95% CI, 85.12–90.73%) for the two test cohorts, respectively.

Conclusion

Using pretreatment US images of the breast cancer, deep learning model enables the assessment of molecular subtypes with high diagnostic accuracy.

Trial registration

Clinical trial number: ChiCTR1900027676

Key Points

• Deep convolutional neural network (DCNN) helps clinicians assess tumor features with accuracy.

• Multicenter retrospective study shows that DCNN derived from pretreatment ultrasound imagine improves the prediction of breast cancer molecular subtypes.

• Management of patients becomes more precise based on the DCNN model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AUC:

Area under the receiver operator characteristic curve

CI:

Confidence interval

DCNN:

Deep convolutional neural network

ER:

Estrogen receptor

HER2:

Human epidermal growth factor receptor 2

IHC:

Immunohistochemical

MCC:

Matthews correlation coefficient

PR:

Progesterone receptor

ROC:

Receiver operating characteristic curve

References

  1. Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132

    Google Scholar 

  2. Haynes B, Sarma A, Nangia-Makker P, Shekhar MP (2017) Breast cancer complexity: implications of intratumoral heterogeneity in clinical management. Cancer Metastasis Rev 36:547–555

    PubMed  PubMed Central  Google Scholar 

  3. Zardavas D, Irrthum A, Swanton C, Piccart M (2015) Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol 12:381–394

    CAS  PubMed  Google Scholar 

  4. Martelotto LG, Ng CK, Piscuoglio S, Weigelt B, Reis-Filho JS (2014) Breast cancer intra-tumor heterogeneity. Breast Cancer Res 16:210

    PubMed  PubMed Central  Google Scholar 

  5. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Prat A, Pineda E, Adamo B et al (2015) Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 24(Suppl 2):S26–S35

    PubMed  Google Scholar 

  7. Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61–70

    Google Scholar 

  8. Prat A, Cheang MCU, Martín M et al (2013) Prognostic significance of progesterone receptor–positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol 31:203–209

    CAS  PubMed  Google Scholar 

  9. Tsoutsou PG, Vozenin MC, Durham AD, Bourhis J (2017) How could breast cancer molecular features contribute to locoregional treatment decision making? Crit Rev Oncol Hematol 110:43–48

    PubMed  Google Scholar 

  10. Ahn HJ, Jung SJ, Kim TH, Oh MK, Yoon H (2015) Differences in clinical outcomes between luminal A and B type breast cancers according to the St. Gallen consensus 2013. J Breast Cancer 18:149–159

    PubMed  PubMed Central  Google Scholar 

  11. Spratt DE, Evans MJ, Davis BJ et al (2015) Androgen receptor upregulation mediates radioresistance after ionizing radiation. Cancer Res 75:4688–4696

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Li X, Zhang S, Zhang Q et al (2019) Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol 20:193–201

    PubMed  Google Scholar 

  13. Ehteshami Bejnordi B, Veta M, Johannes Van Diest P et al (2017) Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 318:2199–2210

    PubMed  PubMed Central  Google Scholar 

  14. Zhou LQ, Wu XL, Huang SY et al (2020) Lymph node metastasis prediction from primary breast cancer US images using deep learning. Radiology 294:19–28

    PubMed  Google Scholar 

  15. Fujioka T, Mori M, Kubota K et al (2019) Breast ultrasound image synthesis using deep convolutional generative adversarial networks. Diagnostics (Basel) 9:176

    Google Scholar 

  16. Xiao T, Liu L, Li K, Qin W, Yu S, Li Z (2018) Comparison of transferred deep neural networks in ultrasonic breast masses discrimination. Biomed Res Int 2018:4605191–4605199

    PubMed  PubMed Central  Google Scholar 

  17. LeCun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521:436–444

    CAS  Google Scholar 

  18. Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Curigliano G, Burstein HJ, Winer EP et al (2017) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol 28:1700–1712

    CAS  PubMed  PubMed Central  Google Scholar 

  20. He K, Gkioxari G, Dollar P, Girshick R (2018) Mask R-CNN. IEEE Trans Pattern Anal Mach Intell 2018:1

    CAS  Google Scholar 

  21. Redmon J, Farhadi A. YOLO9000: better, faster, stronger. Proc IEEE Conf Comput Vis Pattern Recognit 2017; published online Nov 9. https://doi.org/10.1109/CVPR.2017.690

  22. Xie Y, Xia Y, Zhang J et al (2019) Knowledge-based collaborative deep learning for benign-malignant lung nodule classification on chest CT. IEEE Trans Med Imaging 38:991–1004

    PubMed  Google Scholar 

  23. Rajpurkar P, Irvin J, Ball RL et al (2018) Deep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologists. PLoS Med 15:e1002686

    PubMed  PubMed Central  Google Scholar 

  24. Lin T, Goyal P, Girshick R, He K, Dollar P (2020) Focal loss for dense object detection. IEEE Trans Pattern Anal Mach Intell 42:318–327

    PubMed  Google Scholar 

  25. Esteva A, Kuprel B, Novoa RA et al (2017) Dermatologist-level classification of skin cancer with deep neural networks. Nature 542:115–118

    CAS  PubMed  Google Scholar 

  26. Zhou B, Khosla A, Lapedriza A, Oliva A, Torralba A (2016) Learning deep features for discriminative localization. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, pp 2921–2929

  27. Hand DJ, Till RJ (2001) A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach Learn 45:171–186

    Google Scholar 

  28. Hannun AY, Rajpurkar P, Haghpanahi M et al (2019) Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med 25:65–69

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Zhao W, Yang J, Sun Y et al (2018) 3D deep learning from CT scans predicts tumor invasiveness of subcentimeter pulmonary adenocarcinomas. Cancer Res 78:6881–6889

    CAS  PubMed  Google Scholar 

  30. Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321:288–300

    CAS  PubMed  Google Scholar 

  31. Wiechmann L, Sampson M, Stempel M et al (2009) Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol 16:2705–2710

    PubMed  Google Scholar 

  32. Smid M, Wang Y, Zhang Y et al (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68:3108–3114

    CAS  PubMed  Google Scholar 

  33. Chen XS, Wu JY, Huang O et al (2010) Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy. Oncol Rep 23:1213–1220

    CAS  PubMed  Google Scholar 

  34. Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26:1419–1426

    CAS  PubMed  Google Scholar 

  35. Tran B, Bedard PL (2011) Luminal-B breast cancer and novel therapeutic targets. Breast Cancer Res 13:221

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Huber KE, Carey LA, Wazer DE (2009) Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy. Semin Radiat Oncol 19:204–210

    PubMed  Google Scholar 

  37. Liu H, Wan J, Xu G et al (2019) Conventional US and 2-D shear wave elastography of virtual touch tissue imaging quantification: correlation with immunohistochemical subtypes of breast cancer. Ultrasound Med Biol 45:2612–2622

    PubMed  Google Scholar 

  38. Rashmi S, Kamala S, Murthy SS, Kotha S, Rao YS, Chaudhary KV (2018) Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings. Indian J Radiol Imaging 28:354–361

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Mazurowski MA, Zhang J, Grimm LJ, Yoon SC, Silber JI (2014) Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology 273:365–372

    PubMed  Google Scholar 

  40. Presta M, Dell Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159–178

    CAS  PubMed  Google Scholar 

  41. Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299–309

    CAS  PubMed  Google Scholar 

  42. Zhu Z, Albadawy E, Saha A, Zhang J, Harowicz MR, Mazurowski MA (2019) Deep learning for identifying radiogenomic associations in breast cancer. Comput Biol Med 109:85–90

    PubMed  PubMed Central  Google Scholar 

  43. Cejalvo JM, Pascual T, Fernández-Martínez A et al (2018) Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer. Cancer Treat Rev 67:63–70

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank all radiologists of the three hospitals for assisting with collection of the imaging data used in this study.

Funding

This study has received funding by grant from the Project funded by China Postdoctoral Science Foundation (2020M682422), National Natural Science Foundation of China (No. 61976012), Wuhan Science and Technology Bureau (No. 2017060201010181), Health Commission of Hubei Province (WJ2019M077, WJ2019H227), Shihezi Science and Technology Bureau (2019ZH11), Key project supported by the Xinjiang Construction Corps (2019DB012), and Natural Science Foundation of Hubei Province (2019CFB286).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin-Wu Cui.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Professor Xin-Wu Cui.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Only if the study is on human subjects:

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• retrospective

• diagnostic or prognostic study

• multicenter study

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 430 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, M., Zhang, D., Tang, SC. et al. Deep learning with convolutional neural network in the assessment of breast cancer molecular subtypes based on US images: a multicenter retrospective study. Eur Radiol 31, 3673–3682 (2021). https://doi.org/10.1007/s00330-020-07544-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-020-07544-8

Keywords

Navigation